BackgroundAntimicrobials are among the most frequently prescribed medications worldwide, yet their neurocognitive adverse effects remain underrecognized. The adverse effects range from mild symptoms to serious effects and unrecognized adverse effects may influence prescribing behaviors and inappropriate continuation or discontinuation of antimicrobial therapy. Evidence on healthcare providers’ awareness, attitudes, and self-reported clinical management regarding neurocognitive risks is limited,